Media coverage and celebrity interest amplified awareness
Read the full article in ADA Meeting News: To view or add a comment, sign in More Relevant Posts At #ADASciSessions, Klara Klein, MD, PhD, and other experts will discuss emerging trial data examining the potential benefits of GLP-1/GIP receptor agonists for people living with type 1 diabetes
MASLD Risk Extends Beyond Obesity New data show lean individuals with #MASLD face higher risks of liver complications, cancer, and mortality than those with obesitychallenging BMI-based screening and reinforcing the need for earlier, metabolism-focused liver diagnostics
Feng et al., 2022
This hormone not only regulates blood sugar but also curbs appetite, leading to significant weight loss benefits
Nutrition and Kidney Disease, Stages 1-5 (Not on Dialysis)